Fuse Biotherapeutics
Jeffrey Takimoto is the Chief Financial Officer & Chief Business Officer at Fuse Biotherapeutics. He was a former Chief Strategy Officer and CFO at NKMax America, Inc.
Jeffrey holds a PhD in Biology from the University of California, San Diego.
Fuse Biotherapeutics
1 followers
FuseBio is dedicated to developing transformative immune-modulating therapeutics for patients with cancer.